SC
BIVI icon

Saltoro Capital’s BioVie BIVI Stock Holding History

Saltoro Capital’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-150
Closed -$260K – 108
2020
Q4 		$260K Buy
+150
New +$150K 0.13% 100

Other funds holding BIVI

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
S
swisspartners Vaduz, Liechtenstein $78.4M AUM 9.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $2.7B AUM 22.62% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Saltoro Capital's BIVI Position: Q1 2021 in Review

Saltoro Capital sold out of BioVie (BIVI) in Q1 2021, closing a stake of 150 shares — an estimated $260K sold.

Saltoro Capital first reported a position in BIVI in Q4 2020 and held it in 1 quarter. The position peaked at $260K in Q4 2020. 10 funds tracked by Wall St. Rank hold BIVI as of Q1 2021.

  • Saltoro Capital reported no remaining BioVie position as of Q1 2021 after selling out during the quarter.
  • Saltoro Capital sold 150 BioVie shares in Q1 2021, an estimated $260K.
  • Saltoro Capital first reported a position in BioVie in Q4 2020 and held it in 1 quarter.
  • Saltoro Capital's BioVie position peaked at $260K in Q4 2020.
  • 10 funds tracked by Wall St. Rank held BioVie as of Q1 2021.

Based on Saltoro Capital's 13F filing for Q1 2021, filed 14 May 2021.